Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Fullard

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Neuroscience Bulletin|August 24, 2017
Olfactory Dysfunction as an Early Biomarker in Parkinson's DiseaseMichelle E Fullard, James F Morley, John E Duda
BMJ (Clinical Research Ed.)|June 17, 1989
Would primary health care workers give appropriate dietary advice after cholesterol screening?J Francis, M Roche, D Mant, et al.
NPJ Parkinson'S Disease|February 1, 2019
State-level prevalence, health service use, and spending vary widely among Medicare beneficiaries with Parkinson diseaseSneha Mantri, Michelle E Fullard, James Beck, et al.
Journal of Parkinson'S Disease|February 27, 2018
Physical Activity in Early Parkinson DiseaseSneha Mantri, Michelle E Fullard, John E Duda, et al.
Handbook of Clinical Neurology|July 16, 2021
Olfaction as an early marker of Parkinson's disease and Alzheimer's diseaseIan M Walker, Michelle E Fullard, James F Morley, et al.
Movement Disorders Clinical Practice|December 18, 2024
How Women and Men with Parkinson's Disease Approach Decision-Making for Deep Brain Stimulation SurgeryMichelle E Fullard, Ashley Dafoe, Erika Shelton, et al.
Journal of Parkinson'S Disease|February 18, 2026
Development and acceptability of a deep brain stimulation surgery decision aid for Parkinson's diseaseMichelle E Fullard, Erika Shelton, Ashley Dafoe, et al.
Frontiers in Aging Neuroscience|October 30, 2023
Reducing the receipt of contraindicated medications in patients with Parkinson diseaseCaroline Goldin, Stefan Sillau, Elisa Worledge, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2017
Vitamin D in the Parkinson Associated Risk Syndrome (PARS) studyMichelle E Fullard, Sharon X Xie, Ken Marek, et al.
Parkinsonism & Related Disorders|March 1, 2016
Olfactory impairment predicts cognitive decline in early Parkinson's diseaseMichelle E Fullard, Baochan Tran, Sharon X Xie, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Neuroscience Bulletin|August 24, 2017
Olfactory Dysfunction as an Early Biomarker in Parkinson's DiseaseMichelle E Fullard, James F Morley, John E Duda
BMJ (Clinical Research Ed.)|June 17, 1989
Would primary health care workers give appropriate dietary advice after cholesterol screening?J Francis, M Roche, D Mant, et al.
NPJ Parkinson'S Disease|February 1, 2019
State-level prevalence, health service use, and spending vary widely among Medicare beneficiaries with Parkinson diseaseSneha Mantri, Michelle E Fullard, James Beck, et al.
Journal of Parkinson'S Disease|February 27, 2018
Physical Activity in Early Parkinson DiseaseSneha Mantri, Michelle E Fullard, John E Duda, et al.
Handbook of Clinical Neurology|July 16, 2021
Olfaction as an early marker of Parkinson's disease and Alzheimer's diseaseIan M Walker, Michelle E Fullard, James F Morley, et al.
Movement Disorders Clinical Practice|December 18, 2024
How Women and Men with Parkinson's Disease Approach Decision-Making for Deep Brain Stimulation SurgeryMichelle E Fullard, Ashley Dafoe, Erika Shelton, et al.
Journal of Parkinson'S Disease|February 18, 2026
Development and acceptability of a deep brain stimulation surgery decision aid for Parkinson's diseaseMichelle E Fullard, Erika Shelton, Ashley Dafoe, et al.
Frontiers in Aging Neuroscience|October 30, 2023
Reducing the receipt of contraindicated medications in patients with Parkinson diseaseCaroline Goldin, Stefan Sillau, Elisa Worledge, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2017
Vitamin D in the Parkinson Associated Risk Syndrome (PARS) studyMichelle E Fullard, Sharon X Xie, Ken Marek, et al.
Parkinsonism & Related Disorders|March 1, 2016
Olfactory impairment predicts cognitive decline in early Parkinson's diseaseMichelle E Fullard, Baochan Tran, Sharon X Xie, et al.
Pageof 3